Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anomaly42 is a data quality and integrity technology company that provides specialized software solutions for the life sciences and healthcare sectors. The company's platform is designed to identify, investigate, and resolve data anomalies in complex datasets, particularly within clinical trials and regulatory submissions. By ensuring data 'trustworthiness,' Anomaly42 helps pharmaceutical companies and contract research organizations (CROs) mitigate risks, ensure compliance, and accelerate the drug development process. Their technology utilizes advanced algorithms to detect patterns of fraud, error, or inconsistency that traditional methods might miss. The platform serves as a critical tool for quality assurance and risk-based monitoring in highly regulated environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anomaly42.